We herein report on a case of synchronous bilateral breast cancer patient undergoing adjuvant intensity-modulated whole breast with static angle tomotherapy (TomoDirect). The patient was treated with a hypofractionated schedule employing a simultaneous integrated boost approach. Radiotherapy schedule was 45 Gy/20 fractions (2.25 Gy daily) to the bilateral whole breast and 50 Gy/20 fractions (2.5 Gy daily) to the 2 lumpectomy cavities. Treatment was delivered over 4 weeks. Dosimetric results were robust with consistent target coverage and adequate normal tissue avoidance. Treatment was generally well-tolerated and acute toxicity profile was mild. The present report highlights the promising clinical feasibility of TomoDirect for bilateral breast irradiation.
ClarkeM., CollinsR., DarbyS.. Early Breast Cancer Trialist' Collaborative Group (EBCTCG): Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet.2005; 366(9503): 2087–2106.
2.
WarrenS., GatesO.Multiple primary malignant tumours: A survey of the literature and a statistical study. Am J Cancer.1932; 16: 1358–1414.
3.
CarmichaelA.R., BendallS., LockerbieL., PrescottR., BatesT.The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. Eur J Surg Oncol.2002; 28(4): 388–391.
4.
FrancoP., NumicoG., MigliaccioF.. Head and neck region consolidation radiotherapy and prophylactic cranial irradiation with hippocampal avoidance delivered with helical tomotherapy after induction chemotherapy for non-sinonasal neuroendocrine carcinoma of the upper airways. Radiat Oncol.2012; 7(1): 21.
5.
FiandraC., FilippiA.R., CatuzzoP.. Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin's lymphoma: dosimetric comparison and clinical considerations. Radiat Oncol.2012; 7(1): 186.
6.
FrancoP., RicardiU.TomoDirect to deliver static angle tomotherapy treatments. J Nucl Med Radiat Ther.2012; 3: 5.
7.
FrancoP., CatuzzoP., CanteD.. TomoDirect: an efficient means to deliver radiation at static angles with tomotherapy. Tumori.2011; 97(4): 498–502.
8.
CanteD., Rosa La PortaM., Casanova-BorcaV.. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients. Breast J.2011; 17(6): 586–593.
9.
CanteD., FrancoP., SciaceroP.. Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancer. Med Oncol.2013; 30(2): 518.
10.
CanteD., FrancoP., SciaceroP.. Hypofractionation and concomitant boost to deliver adjuvant whole-breast radiation in ductal carcinoma in situ (DCIS): a subgroup analysis of a prospective case series. Med Oncol.2014; 31(2): 838.
11.
CatuzzoP., ZenoneF., AimonettoS.. Technical note: patient-specific quality assurance methods for TomoDirect(TM) whole breast treatment delivery. Med Phys.2012; 39(7): 4073–4078.
12.
RampinoM., RicardiU., MunozF.. Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial. Clin Oncol (R Coll Radiol).2011; 23(2): 134–140.
13.
RicardiU., RaccaP., FrancoP.. Prospective phase II trial of neoadjuvant chemo-radiotherapy with oxaliplatin and capecitabine in locally advanced rectal cancer (XELOXART). Med Oncol.2013; 30(2): 581.
TerrazzinoS., La MattinaP., GambaroG.. Common variants of GSTP1, GSTA1, and TGFβ1 are associated with the risk of radiation-induced fibrosis in breast cancer patients. Int J Radiat Oncol Biol Phys.2012; 83(2): 504–511.
16.
BorcaV.C., FrancoP., CatuzzoP.. Does TomoDirect 3DCRT represent a suitable option for post-operative whole breast irradiation? A hypothesis-generating pilot study. Radiat Oncol.2012; 7(1): 211.
17.
FrancoP., ZeverinoM., MigliaccioF.. Intensity-modulated adjuvant whole breast radiation delivered with static angle tomotherapy (TomoDirect): a prospective case series. J Cancer Res Clin Oncol.2013; 139(11): 1927–1936.
18.
FrancoP., ZeverinoM., MigliaccioF.. Intensity-modulated and hypofractionated simultaneous integrated boost adjuvant breast radiation employing statics ports of tomotherapy (TomoDirect): a prospective phase II trial. J Cancer Res Clin Oncol.2014; 140(1): 167–177.
